TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.

Amanda N Fader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.